Clinical Trial Update: Safety and Potency of a High Cabergoline Dosage in Microprolactinomas [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the safety and efficacy of a high-dose cabergoline regimen in people with microprolactinomas. The study is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperprolactinemia
• Prolactinoma

Drugs mentioned

• CABERGOLINE (CABERGOLINE)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Prolactinoma, Prolactin Excess | Phase 3 | Status: RECRUITING